iCubed Information

The Institute for Immunology and Informatics (iCubed) was established in 2008 under the leadership of Annie De Groot as part of the University of Rhode Island's (URI) emerging biotechnology program. The institute maintains offices and laboratory space in the historic Shepard Building as part of URI's Feintstein Providence Campus. Both of iCubed's Chief Scientists, Dr's. Anne De Groot and Alan Rothman, are recognized as leaders in their field, not only for their research expertise, but also for their ability to foster collaboration and mentor the next generation of scientists. Anne De Groot, M.D. is recognized for her "genome-to-vaccine" methodologies. Her team at iCubed applies cutting-edge bioinformatic tools to accelerate the development of treatments and cures for a number of diseases such as HIV, Influenza and Burkholderia. The Institute aims to quickly make these tools available to the global research community. VaccineNation names Dr. De Groot as one of the most influential people contributing to the vaccine industry. Alan Rothman, M.D. has recently garnered over $20M in NIH funding and has notably established URI's first Center of Biomedical Research Excellence (COBRE). Additionally, Dr. Rothman serves as the Director for the Dengue Hemorrhagic Fever Project a longstanding research collaboration involving studies of dengue virus transmission, infection, and illness with an overall goal of advancing the treatment and prevention of disease.